Home › Blastic Plasmacytoid Dendritic Cell Cancer › Washington
Blastic Plasmacytoid Dendritic Cell Cancer clinical trials in Washington
4 studies for Blastic Plasmacytoid Dendritic Cell Cancer are looking for participants at sites in Washington.
Cities in Washington
Cord Blood Transplant, Cyclophosphamide, Fludarabine, and Total-Body Irradiation in Treating Patients With High-Risk Hematologic Diseases
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RecruitingPhase 2
6 Months – 65 Years · All sexes · Updated Jul 22, 2026 · NCT06013423Blastic Plasmacytoid Dendritic Cell Neoplasm (BPDCN) International Registry
- Seattle Children's Cancer and Blood Disorders Center, Seattle
RecruitingObservational study
All ages · All sexes · Updated Jun 5, 2026 · NCT05430971HA-1 T TCR T Cell Immunotherapy for the Treatment of Patients With Relapsed or Refractory Acute Leukemia After Donor Stem Cell Transplant
- Fred Hutch/University of Washington Cancer Consortium, Seattle
RecruitingPhase 1
Up to age 80 · All sexes · Updated May 18, 2026 · NCT03326921Tagraxofusp in Pediatric Patients With Relapsed or Refractory CD123 Expressing Hematologic Malignancies
- Seattle Children's Hospital, Seattle
RecruitingPhase 1
Ages 1 to 21 · All sexes · Updated Dec 6, 2024 · NCT05476770From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.